Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"

NCT02181816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1090

Last updated 2019-06-03

Study results available
· View outcomes & findings →

Summary

The purpose of this survey is to evaluate the safety and efficacy of long-term use of azilsartan/amlodipine combination tablets Low Dose (LD) \& High Dose (HD) (Zacras Combination Tablets LD \& HD) in hypertensive patients in daily medical practice.

Conditions

Interventions

DRUG

Azilsartan/Amlodipine

Azilsartan/Amlodipine combination tablets LD \& HD

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-26
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02181816 on ClinicalTrials.gov